Affordable Access

Publisher Website

An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.

Authors
Type
Published Article
Journal
Cancer Letters
0304-3835
Publisher
Elsevier
Publication Date
Volume
357
Issue
1
Pages
364–373
Identifiers
DOI: 10.1016/j.canlet.2014.11.054
PMID: 25434798
Source
Medline
Keywords
  • Diabody
  • Egfr
  • Onconase
  • Ranpirnase
  • Immunornase

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments